PROFUSA Revenue 2022-2025 | PFSA

PROFUSA revenue from 2022 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
PROFUSA Annual Revenue
(Millions of US $)
2024
2023
2022
2021
PROFUSA Quarterly Revenue
(Millions of US $)
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30 $0
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.002B $0.000B
Profusa Inc. is a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual's biochemistry. Profusa Inc., formerly known as NorthView Acquisition Corp., is based in BERKELEY, Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $28.621B 33.10
Tempus AI (TEM) United States $9.242B 0.00
IRhythm Holdings (IRTC) United States $4.646B 0.00
Doximity (DOCS) United States $4.621B 20.02
Hims & Hers Health (HIMS) United States $3.711B 30.18
Hinge Health (HNGE) United States $3.065B 0.00
Privia Health (PRVA) United States $2.754B 172.23
10x Genomics (TXG) United States $2.293B 0.00
Heartflow (HTFL) United States $1.759B 0.00
Inspire Medical Systems (INSP) United States $1.736B 23.16
Omnicell (OMCL) United States $1.638B 45.62
Azenta (AZTA) United States $1.318B 53.00
Enovis (ENOV) United States $1.245B 6.54
Clover Health Investments (CLOV) United States $1.044B 0.00
Schrodinger (SDGR) United States $0.840B 0.00
Butterfly Network (BFLY) United States $0.768B 0.00
Fulgent Genetics (FLGT) United States $0.724B 0.00
Phreesia (PHR) United States $0.720B 0.00
Talkspace (TALK) United States $0.625B 125.67
Standard BioTools (LAB) United States $0.431B 0.00
Claritev (CTEV) United States $0.380B 0.00
Zepp Health (ZEPP) Netherlands $0.338B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.320B 0.00
Evolent Health (EVH) United States $0.311B 0.00
Senseonics Holdings (SENS) United States $0.307B 0.00
TruBridge (TBRG) United States $0.293B 13.45
Carlsmed (CARL) United States $0.291B 0.00
CapsoVision (CV) United States $0.226B 0.00
KORU Medical Systems (KRMD) United States $0.216B 0.00
MDxHealth SA (MDXH) Belgium $0.161B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.160B 0.00
Nyxoah SA (NYXH) Belgium $0.151B 0.00
Health Catalyst (HCAT) United States $0.130B 0.00
CareCloud (CCLD) United States $0.098B 5.40
American Well (AMWL) United States $0.088B 0.00
111 (YI) China $0.070B 0.00
NetraMark Holdings (AINMF) Canada $0.064B 0.00
Outset Medical (OM) United States $0.062B 0.00
Pulmonx (LUNG) United States $0.061B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Precipio (PRPO) United States $0.041B 0.00
EUDA Health Holdings (EUDA) Singapore $0.032B 0.00
Evaxion - (EVAX) Denmark $0.028B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
Lunai Bioworks (LNAI) United States $0.017B 0.00
P3 Health Partners (PIII) United States $0.015B 0.00
Movano (MOVE) United States $0.013B 0.00
HeartSciences (HSCS) United States $0.010B 0.00
ITonic Holdings (ITOC) China $0.007B 0.00
Zhongchao (ZCMD) China $0.005B 0.00
Bullfrog AI Holdings (BFRG) United States $0.005B 0.00
Strata Skin Sciences (SSKN) United States $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00